Literature DB >> 11704834

Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.

T D Gilmore1, C Cormier, J Jean-Jacques, M E Gapuzan.   

Abstract

Rel/NF-kappaB transcription factors control a variety of cellular processes, such as cell growth and apoptosis, that are relevant to oncogenesis, and mutations in genes encoding Rel/NF-kappaB transcription factors have been found in several human lymphoid cell cancers. In this study, we have used a sensitive cell outgrowth assay to demonstrate that wild-type human c-Rel can malignantly transform primary chicken spleen cells, and that transformation by c-Rel is accelerated by co-expression of Bc1-2. Full-length mouse c-Rel can also transform chicken spleen cells. These results are the first demonstration of a lymphoid cell malignant transforming ability for mammalian Rel/NF-kappaB transcription factors, and implicate c-Rel as a molecular target for cancer therapeutics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704834     DOI: 10.1038/sj.onc.1204898

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  25 in total

1.  Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.

Authors:  Béatrice Rayet; Yongjun Fan; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

2.  CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.

Authors:  Jui Dutta; Gaofeng Fan; Céline Gélinas
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

3.  The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth.

Authors:  Kathryn E King; Roshini M Ponnamperuma; Clint Allen; Hai Lu; Praveen Duggal; Zhong Chen; Carter Van Waes; Wendy C Weinberg
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

4.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

5.  Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival.

Authors:  Lan V Pham; Archito T Tamayo; Linda C Yoshimura; Yen-Chiu Lin-Lee; Richard J Ford
Journal:  Blood       Date:  2005-08-11       Impact factor: 22.113

6.  Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.

Authors:  Michael R Garbati; Gökçen Alço; Thomas D Gilmore
Journal:  Cancer Lett       Date:  2009-11-30       Impact factor: 8.679

7.  Stimulation of c-Rel transcriptional activity by PKA catalytic subunit beta.

Authors:  Shih-Hung Yu; Wei-Chung Chiang; Hsiu-Ming Shih; Kou-Juey Wu
Journal:  J Mol Med (Berl)       Date:  2004-06-09       Impact factor: 4.599

8.  A distinctive physiological role for IkappaBbeta in the propagation of mitochondrial respiratory stress signaling.

Authors:  Gopa Biswas; Weigang Tang; Neal Sondheimer; Manti Guha; Seema Bansal; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2008-02-13       Impact factor: 5.157

9.  Peptidyl-prolyl isomerase Pin1 markedly enhances the oncogenic activity of the rel proteins in the nuclear factor-kappaB family.

Authors:  Gaofeng Fan; Yongjun Fan; Nupur Gupta; Isao Matsuura; Fang Liu; Xiao Zhen Zhou; Kun Ping Lu; Céline Gélinas
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

10.  Mouse mammary tumor virus c-rel transgenic mice develop mammary tumors.

Authors:  Raphaëlle Romieu-Mourez; Dong W Kim; Sang Min Shin; Elizabeth G Demicco; Esther Landesman-Bollag; David C Seldin; Robert D Cardiff; Gail E Sonenshein
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.